Compound ID | 2704
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus; dissipates proton motive force |
| Propensity to select resistant mutants: | Yes, low (10^-8 frequency after 30 days) |
| Description: | A result of deep-learning model prediction of structural class with selective antibiotic activity (deep learning approach); >8-fold selectivity (human cell IC50 vs MIC); compound 1 - link to structure (1); compound 2 - link to structure (2) |
| Institute where first reported: | Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research and David Braley Centre for Antibiotic Discovery, McMaster University, Hamilton, Ontario, Canada |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||||
|
|
||||||||||||
|
|
||||||||||||
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/1314498 |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/2942818 |
| Citation: | https://www.nature.com/articles/s41586-023-06887-8#Sec10 |